Related Experiment Video
Updated: Aug 16, 2026
Noninvasive Monitoring of Lesion Size in a Heterologous Mouse Model of Endometriosis
Published on: February 26, 2019
Selective localization of interleukin-1 receptor antagonist in eutopic endometrium and endometriotic implants
V Sahakian1, J Anners, S Haskill
1Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill 27599.
Objectives:
To determine whether interleukin-1 receptor antagonist (IL-1ra) expression was concordant in eutopic endometrium and endometriotic implants.
Design:
Paired samples of endometrium and endometriotic implants from eight patients with endometriosis were used.
Main Outcome Measures:
Interleukin-1 receptor antagonist was demonstrated immunohistochemically on frozen sections of eutopic and ectopic endometria. A sandwich technique with polyclonal rabbit anti-IL-1ra antibody and an avidin-biotin reagent (Vector Laboratories, Inc. Burlingame, CA) was used.
Results:
Seven of eight (88%) eutopic endometrial sections revealed staining of glandular epithelium with complete absence of any staining of the stromal compartment. In the counterpart sections of endometriosis, the glandular as well as the stromal compartments were negative for IL-1ra in all patients.
Conclusion:
These data suggest a differential production of the IL-1ra in eutopic endometrium and endometriotic implants. The potential clinical implications of this finding are discussed.
More Related Videos
07:46Platform for Quantitative Detection of Endometrial Immune Cells Based on Immunohistochemistry and Digital Image Analysis
Published on: October 13, 2023
08:29Measurement of Four Uterine NK Cell Subtypes Using Multiplexed Fluorescent Immunohistochemical Staining in Women with Repeated Implantation Failure
Published on: October 25, 2024